Real-World Clinical Effectiveness and Tolerability of Hydroxychloroquine 400 Mg in Uncontrolled Type 2 Diabetes Subjects who are not Willing to Initiate Insulin Therapy (HYQ-Real-World Study).
CONCLUSION: Add-on treatment of HCQ effectively improved glycemic control in T2DM patients uncontrolled on multiple antidiabetic drugs. By virtue of its antidiabetic and anti-inflammatory properties, it may emerge as a valuable therapeutic intervention for the patients with T2DM.
PMID: 31713476 [PubMed - in process]
Source: Current Diabetes Reviews - Category: Endocrinology Authors: Gupta A Tags: Curr Diabetes Rev Source Type: research
More News: Actos | Anxiety | Canagliflozin | Dapagliflozin | Diabetes | Diabetes Type 2 | Empagliflozin | Endocrinology | Epidemics | Epidemiology | Fortamet | Forxiga | Glimepiride | Hydroxychloroquine | Insulin | Invokana | Janumet | Januvia | Jardiance | Metformin | Study | Sugar